Fredrik Erlandsson
- Biophysics top 1%
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 6
- Molecular Biology top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses 3
- IL-33, ST2, and ILC Pathways 3
- Oncology top 10%
- Cancer-related Molecular Pathways 4
-
- Renal cell carcinoma treatment 4
-
- Cancer Genomics and Diagnostics 4
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Ewert BengtssonCarolina WählbyIda‐Maria SintornG. BorgeforsAnders ZetterbergAndrea HarzstarkDamian A. LaberHarry A. Drabkin
- Journals
- Journal of Clinical Oncology (6 papers)Gastroenterology (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Fredrik Erlandsson
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Biophysics 204
- Nephrology 116
- Molecular Biology 759
- Immunology 219
- Oncology 255
Countries citing papers authored by Fredrik Erlandsson
This map shows the geographic impact of Fredrik Erlandsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Erlandsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Erlandsson more than expected).
Fields of papers citing papers by Fredrik Erlandsson
This network shows the impact of papers produced by Fredrik Erlandsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Erlandsson. The network helps show where Fredrik Erlandsson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fredrik Erlandsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2021 | 3 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 54 | |
| 5 | 2019 | 1 | |
| 6 | 2015 | 36 | |
| 7 | 2014 | 123 | |
| 8 | 2013 | 326 | |
| 9 | 2011 | 78 | |
| 10 | 2010 | 11 | |
| 11 | 2010 | 2 | |
| 12 | 2009 | 4 | |
| 13 | 2007 | 19 | |
| 14 | 2006 | 10 | |
| 15 | 2005 | 28 | |
| 16 | 2004 | 259 | |
| 17 | 2003 | 54 | |
| 18 | 2003 | 20 | |
| 19 | Multiple tissue antigen analysis by sequential immunofluorescence staining and multi-dimensional image analysis | 2001 | 4 |
| 20 | 2000 | 60 |
About Fredrik Erlandsson
Fredrik Erlandsson is a scholar working on Nephrology, Transplantation and Oncology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (6 papers), Renal cell carcinoma treatment (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer Genomics and Diagnostics (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). The work is most often cited by research in Biophysics (204 citations), Nephrology (116 citations) and Molecular Biology (759 citations). Fredrik Erlandsson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Ewert Bengtsson, Carolina Wählby, Ida‐Maria Sintorn, G. Borgefors, Anders Zetterberg, Andrea Harzstark, Damian A. Laber, Harry A. Drabkin, Gregory W. Smith and Robert A. Figlin. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.